CoChat

Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma

Open access

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

BACKGROUND: A major molecular pathway of genetic instability in cancer is DNA mismatch repair deficiency. High-level microsatellite instability (MSI-H) is currently the best predictor of responsiveness towards immune checkpoint blockade. Data about the prevalence of high-level microsatellite instability in cholangiocarcinoma (CCA) has been conflicting. METHODS: We employed a cohort comprising 308 Western-world, non-liver fluke-associated CCAs (159 intrahepatic, 106 perihilar, and 43 distal). We analysed the mononucleotide microsatellite instability marker panel consisting of BAT25, BAT26, and CAT25 and detected MSI-H in 4/308 CCAs (1.3%). RESULTS: Patients affected by MSI-H CCA had mostly an atypical histomorphology (p = 0.004), showed a longer overall survival, although having a high tumour stage, and were of younger age. Correlation analysis of microsatellite instability status with tumour-infiltrating immune cells, MHC I, and PD-L1 expression in the same cholangiocarcinoma cohort showed higher numbers of CD8 + T cells, FOXP3 + regulatory T cells, CD20 + B cells and high or at least moderate MHC I expression levels in MSI-H CCAs. CONCLUSIONS: Even though the overall number of MSI-H CCAs is low, the dismal prognosis of the disease and the therapeutic option of immune checkpoint blockade in the respective patients justify MSI testing of cholangiocarcinoma, particularly in younger patients showing an atypical histomorphology.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41416-018-0199-2

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 Immunohistochemistry of two representative microsatellite-unstable cases. Full slide sections of one microsatellite-unstable intrahepatic cholangiocarcinoma with papillary morphology (left sided column: a, c, e, g, i) showing loss of nuclear MLH1 and PMS2 immunoreactivity while MSH2 and MSH6 were retained. Full slide sections of one microsatellite-unstable perihilar cholangiocarcinoma (right sided column: b, d, f, h, j) showing loss of nuclear PMS2 immunoreactivity while MLH1, MSH2, and MSH6 were retained. Original magnification: 40× (H&E; a, b), 100x (c–j), 200× (insets of d and f)
Fig. 1 Immunohistochemistry of two representative microsatellite-unstable cases. Full slide sections of one microsatellite-unstable intrahepatic cholangiocarcinoma with papillary morphology (left sided column: a, c, e, g, i) showing loss of nuclear MLH1 and PMS2 immunoreactivity while MSH2 and MSH6 were retained. Full slide sections of one microsatellite-unstable perihilar cholangiocarcinoma (right sided column: b, d, f, h, j) showing loss of nuclear PMS2 immunoreactivity while MLH1, MSH2, and MSH6 were retained. Original magnification: 40× (H&E; a, b), 100x (c–j), 200× (insets of d and f)CC BY · PubMed Central
Fig. 2 Overall survival probability in cholangiocarcinoma patients in correlation with high-level microsatellite instability status. Kaplan–Meier curves show a longer overall survival of microsatellite-unstable cholangiocarcinoma patients in correlation with microsatellite-stable cholangiocarcinoma patients (p = 0.097). P-value was calculated by log-rank test. Survival data were available for 285 of 308 (92.5%) cholangiocarcinoma patients
Fig. 2 Overall survival probability in cholangiocarcinoma patients in correlation with high-level microsatellite instability status. Kaplan–Meier curves show a longer overall survival of microsatellite-unstable cholangiocarcinoma patients in correlation with microsatellite-stable cholangiocarcinoma patients (p = 0.097). P-value was calculated by log-rank test. Survival data were available for 285 of 308 (92.5%) cholangiocarcinoma patientsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Cited by

See all 108

Metadata

Authors
Goeppert, B., Roessler, S., Renner, M., Singer, S., Mehrabi, A., Vogel, M. N., Pathil, A., Czink, E., Köhler, B., Springfeld, C., Pfeiffenberger, J., Rupp, C., Weiss, K. H., Schirmacher, P., von Knebel Doeberitz, M., & Kloor, M.
Affiliations
  • University Hospital Heidelberg (DE)
  • Heidelberg University (DE)
Corresponding author
Goeppert, Benjamin
Venue
British Journal of Cancer
Published
2018-10-31
Volume
120
Issue
1
Pages
109-114
ISSN
  • 0007-0920 (ISSN-L)
  • 1532-1827
OpenAlex
W2898899606
Cited by
108
References
25
Citations by year
2026: 5 · 2025: 14 · 2024: 19 · 2023: 17 · 2022: 22 · 2021: 11 · 2020: 10 · 2019: 10
FWCI
8.06
Type
journal article
Language
en
Open access
Licence
  • cc-by
  • creativecommons.org/licenses/by/4.0 (tdm)
Locations
  • British Journal of Cancer (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Funders
Deutsche Forschungsgemeinschaft (SFB/TR 209)
Topics
  • Health Sciences › Medicine › Surgery › Cholangiocarcinoma and Gallbladder Cancer Studies
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Genetic factors in colorectal cancer
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
cholangiocarcinoma, mismatch repair deficiency, microsatellite instability, microsatellite instability-high, immune checkpoint blockade, BAT25, BAT26, tumor-infiltrating immune cells, MHC class I expression, PD-L1 expression, overall survival
MeSH terms
Adult, Aged, Brain Neoplasms, Female, Humans, Liver, Male, Middle Aged, Neoplasm Staging, Neoplastic Syndromes, Hereditary, Prognosis, Colorectal Neoplasms, Cholangiocarcinoma, CD8-Positive T-Lymphocytes, Microsatellite Repeats, Antigens, CD20, Forkhead Transcription Factors, Microsatellite Instability, DNA Mismatch Repair, B7-H1 Antigen

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma. https://app.cochat.ai/papers/10.1038/s41416-018-0199-2
The paper
Goeppert, B., Roessler, S., Renner, M., Singer, S., Mehrabi, A., Vogel, M. N., Pathil, A., Czink, E., Köhler, B., Springfeld, C., Pfeiffenberger, J., Rupp, C., Weiss, K. H., Schirmacher, P., von Knebel Doeberitz, M., & Kloor, M. (2019). Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma. British Journal of Cancer. https://doi.org/10.1038/s41416-018-0199-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.